@article{8478fc4de8bb41178ff337f4ace4091c,
title = "Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism",
author = "Wells, {Philip S.} and Tobias Tritschler and Faizan Khan and Anderson, {David R.} and Kahn, {Susan R.} and Alejandro Lazo-Langner and Marc Carrier and {Le Gal}, Gr{\'e}goire and Castellucci, {Lana A.} and Vinay Shah and Scott Kaatz and Clive Kearon and Susan Solymoss and Russell Zide and Sam Schulman and Isabelle Chagnon and Ranjeeta Mallick and Rodger, {Marc A.} and Kovacs, {Michael J.}",
note = "Funding Information: Conflict-of-interest disclosure: PW reports receiving honoraria for advisory board meetings from Bayer Healthcare, Sanofi, and Daiichi Sankyo, and Research Funding from BMS/Pfizer. LC has received honoraria from Amag Pharmaceuticals, Bayer Healthcare, BMS-Pfizer Alliance, The Academy, LEO Pharma, Sanofi, Servier, and Valeo. All payments were made to her institution. MC has received research funding from Leo Pharma, BMS, and Pfizer, and honoraria from Bayer, Sanofi, Servier, BMS, Pfizer, and LEO Pharma. All payments were made to his institution. GLG reports support from Portola Pharmaceuticals, Boehringer Ingelheim, Pfizer BMS, LEO Pharma, Daiichi Sankyo, Bayer, Sanofi, and bioMerieux. All payments were made to his institution. S.K. received a grant to develop educational materials from Alexion. S. Schulman has received research grant from Octapharma and honoraria for work in study committees from Daiichi-Sankyo, Boehringer Ingelheim, Bayer, and Sanofi, and for lectures from Servier and Bristol Myers Squibb. The remaining authors declare no competing financial interests. Funding Information: P.S.W., T.T., F.K., D.R.A., S.R.K., A.L.-L., M.C., G.L.G., L.A.C., C.K., S. Solymoss, S. Schulman, I.C., M.J.K., and M.A.R. are investigators of the CanVECTOR Network; the Network receives grant funding from the Canadian Institutes of Health Research (Funding Reference: CDT-142654). T.T.{\textquoteright}s research was supported by grants from the Swiss National Science Foundation (SNSF P2ZHP3_177999) and the CanVECTOR Network. F.K. was supported by the Frederick Banting and Charles Best doctoral research scholarship from the Canadian Institutes of Health Research. S.R.K. holds a Tier 1 Canada Research Chair in Venous Thromboembolism. P.S.W., M.C., and G.L.G. all hold a Clinical Research Chair from the Department and Faculty of Medicine of the University of Ottawa. G.L.G. also holds a Clinician-scientist Award from the Heart and Stroke Foundation of Canada. L.A.C. is supported by a Tier 2 Research Chair in Thrombosis and Anticoagulation Safety from the Department and Faculty of Medicine of the University of Ottawa and a Heart and Stroke Foundation of Canada National New Investigator Award. M.A.R. is the McGill University Harry Webster Thorp Professor of Medicine. Funding Information: This investigator-initiated study was sponsored by the Ottawa Hospital Research Institute and funded by grants from the Canadian Institutes of Health Research (MOP130388) and the Heart and Stroke Foundation of Canada. The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit the article for publication. Publisher Copyright: {\textcopyright} 2022 by The American Society of Hematology.",
year = "2022",
month = aug,
day = "9",
doi = "10.1182/bloodadvances.2022007027",
language = "English",
volume = "6",
pages = "4605--4616",
journal = "Blood Advances",
issn = "2473-9529",
publisher = "Elsevier BV",
number = "15",
}